Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Neostigmine price, strengths & recalls

Neostigmine has no weekly pharmacy acquisition cost. 7 manufacturers make it. It is in shortage (being discontinued). It has 30 recalls on record, none ongoing. Its official label last changed on January 19, 2024.

Being discontinuedGeneric
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Neostigmine price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
1 mg/mL injectionNot priced this week
1 mg/mL, 3 mL prefilled syringeNot priced this week

Supply status: shortages & recalls

In shortage1 product is short or being discontinued
No ongoing recalls30 recalls on record, latest Apr 3, 2024

Shortages

  • Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)Fresenius Kabi USA, LLC · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 30 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for neostigmine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJanuary 19, 2024
Version16 of 6
EffectiveJan 1, 2024
Read the label

These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively.See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION.NEOSTIGMINE METHYLSULFATE injection, for intravenous useInitial U.S. Approval: 1939

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA203629 · Fresenius Kabi USA
First approved
January 8, 2015 (11 years ago)
Latest approved change
February 4, 2021
Approved label
PDF, Feb 8, 2021
Generic makers
7 approved generic applications on the market

Neostigmine questions

Is neostigmine in shortage?

Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.

Has neostigmine been recalled?

30 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the neostigmine label last change?

The official label was last updated on January 19, 2024 (version 16). See what changed.

Talk about neostigmine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.